Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:47 AM
Ignite Modification Date:
2025-12-24 @ 11:47 AM
NCT ID:
NCT02645461
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of ALS according to the El-Escorial criteria;
* Age\> 18 years;
* ALS Functional Rating Scale-Revised (ALSFRS- r) score\> 20;
* Forced Vital Capacity (FVC)\> 30%;
* Treatment with Riluzole.
Exclusion Criteria:
* Other diseases motor neurons;
* Experimental treatments in the previous three months;
* Pregnant or breast-feeding;
* Contraindications to the use of riluzole;
* Patients undergoing tracheostomy, enteral or parenteral supply;
* Severe psychiatric disorders.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02645461
Study Brief:
Protocol Section:
NCT02645461